Form 4 for IDXX Idexx Laboratories
Accepted 2021-11-15 00:00:00 ET · period of report 2021-11-12 · accession 0001567619-21-020493 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-15 | 2021-11-12 | IDXX | MCKEON BRIAN P | CFO, Executive VP | S - Sale+OE | $620.72 | -9,225 | 26.3K | -26% | -$5.73M |
| D | 2021-11-15 | 2021-11-12 | IDXX | MCKEON BRIAN P | CFO, Executive VP | M - OptEx | $67.85 | +9,225 | 35.5K | +35% | +$625.9K |
| D | 2021-11-15 | 2021-11-12 | IDXX | MCKEON BRIAN P | CFO, Executive VP | M - OptEx | — | -9,225 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-12 | S | D | 6,952 | $620.55 | 28,589.64 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $620.00 to $621.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2021-11-12 | S | D | 2,273 | $621.26 | 26,316.64 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $621.045 to $621.815. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2021-11-12 | M | A | 9,225 | $67.85 | 35,541.64 | D | — | — | |
| 4 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2021-11-12 | M | D | 9,225 | — | 0 | D | $67.85 · — to 2026-02-13 | 9,225 Common Stock | (F4) Not applicable. (F3) Grant of option to buy 45,535 shares of IDEXX Laboratories, Inc. common stock that vested in five annual installments beginning February 14, 2017. |